Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial

Background: The rapid worldwide spread of the Omicron variant of SARS-CoV-2 has unleashed a new wave of COVID-19 outbreaks. The efficacy of molnupiravir, an approved drug, is still unknown in patients infected with the Omicron variant. Objective: Evaluated the antiviral efficacy and safety of molnup...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Rongrong, Peng, Ling, Shu, Dan, Zhao, Lei, Lan, Jianfeng, Tan, Guoyu, Peng, Jinghan, Yang, Xiangyi, Liu, Miaona, Zhang, Chenhui, Yuan, Jing, Wang, Huxiang, Li, Song, Lu, Hongzhou, Zhong, Wu, Liu, Yingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248931/
https://www.ncbi.nlm.nih.gov/pubmed/35784723
http://dx.doi.org/10.3389/fphar.2022.939573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248931/
https://www.ncbi.nlm.nih.gov/pubmed/35784723
http://dx.doi.org/10.3389/fphar.2022.939573

Ejemplares similares